ask="2.15"
ask_size="15000"
average_daily_volume="2281330"
bid="2.12"
bid_size="3000"
book_value="4.53"
change="-0.05"
change_from_200_day_moving_average="-0.57"
change_from_50_day_moving_average="-0.12"
change_from_52_week_high="-1.70"
change_From_52_week_low="0.21"
change_in_percent="-2.28%"
close="2.14"
dividend_pay_date="6/13/2016"
dividend_per_share="0.20"
dividend_yield="9.01"
earnings_per_share="1.06"
ebitda="244.51M"
eps_estimate_current_year="0.54"
eps_estimate_next_quarter="0.07"
eps_estimate_next_year="0.20"
ex_dividend_date="6/2/2016"
float_shares="150390000"
high="2.21"
high_52_weeks="3.84"
last_trade_date="2/28/2017"
last_trade_price="2.14"
last_trade_size="199306"
last_trade_time="4:00pm"
low="2.11"
low_52_weeks="1.93"
market_capitalization="354.26M"
moving_average_200_day="2.71"
moving_average_50_day="2.26"
name="PDL BioPharma
Inc."
notes="N/A"
one_year_target_price="3.67"
open="2.17"
pe_ratio="2.02"
peg_ratio="0.30"
percent_change_from_200_day_moving_average="-21.01%"
percent_change_from_50_day_moving_average="-5.41%"
percent_change_from_52_week_high="-44.27%"
percent_change_from_52_week_low="+10.88%"
previous_close="2.19"
price_eps_estimate_current_year="3.96"
price_eps_Estimate_next_year="10.70"
price_per_book="0.48"
price_per_sales="1.27"
revenue="286.16M"
shares_outstanding="165540000"
short_ratio="5.06"
stock_exchange="NMS"
symbol="PDLI"
volume="2092121"
weeks_range_52="1.93 - 3.84"
